204 The role of immune checkpoint inhibitor as a single agent or combination therapy in advanced thyroid cancer

• Eugene Kim,
• Young Kwang Chae,
• Elena Vagia,
• Myungwoo Nam,
• Chan Mi Jung,
• Christmann Low,
• Ju Young Lee,
• Hansol Choi,
• Inae Park

Affiliations

Eugene Kim

1Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Young Kwang Chae

Aff1 Developmental Therapeutics Program of the Division of Hematology Oncology, Early Phase Clinical Trials Unit 645 N. Michigan Avenue, Suite 1006 60611 Chicago IL USA

Elena Vagia

Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, Oak Park, IL, USA

Myungwoo Nam

1Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Chan Mi Jung

2Northwestern University Weinberg School of Arts and Sciences, Chicago, IL, USA

Christmann Low

2Northwestern University Weinberg School of Arts and Sciences, Chicago, IL, USA

Ju Young Lee

1Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Hansol Choi

1Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Inae Park

Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, Oak Park, IL, USA